{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-004161","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2024-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.947127+00:00","generated_at":"2026-06-06T15:47:46.900184+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Harrow expands board to six members, appoints Dr. Adrienne Graves and Lauren Silvernail","bullets":["Board size increased from 4 to 6 members effective January 26, 2024.","Dr. Adrienne Graves brings ophthalmology expertise as former CEO of Santen Inc. and board member at multiple eye-care firms.","Lauren Silvernail brings financial and strategic expertise as former CFO of Evolus, Revance, and ISTA Pharmaceuticals.","Appointments are effective immediately; press release issued January 29, 2024.","Neither new director has been assigned to a board committee at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-004161","json":"https://secwatch.observer/filing/0001493152-24-004161.json","markdown":"https://secwatch.observer/filing/0001493152-24-004161.md","text":"https://secwatch.observer/filing/0001493152-24-004161.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224004161/0001493152-24-004161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224004161/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:47:46.900184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8d3a4b97ea","claim":"Lauren P. Silvernail was elected as Director at HARROW, INC..","evidence_excerpt":"On January 26, 2024 (the “Effective Date”), the board of directors (the “Board”) of Harrow, Inc. (the “Company”), following the recommendation of the Nomination and Corporate Governance Committee of the Board, expanded the size of the Board from four members to six and elected Adrienne L. Graves, Ph.D. and Lauren P. Silvernail to serve as members of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224004161/0001493152-24-004161-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"ff16dbbc74","claim":"Adrienne L. Graves was elected as Director at HARROW, INC..","evidence_excerpt":"On January 26, 2024 (the “Effective Date”), the board of directors (the “Board”) of Harrow, Inc. (the “Company”), following the recommendation of the Nomination and Corporate Governance Committee of the Board, expanded the size of the Board from four members to six and elected Adrienne L. Graves, Ph.D. and Lauren P. Silvernail to serve as members of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315224004161/0001493152-24-004161-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}